Aurinia Pharmaceuticals (AUPH) Cash from Investing Activities (QoQ) (2015 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Quantum Biopharma | 1,216,509.61 Bn | 1,216,509.61 Bn | - |
| 2 | Alterity Therapeutics | 764,224.41 Bn | 764,224.38 Bn | - |
| 3 | Legend Biotech | 2,716.00 Bn | 2,715.71 Bn | 242.10 Mn |
| 4 | Nanobiotix | 2,248.83 Bn | 2,248.77 Bn | - |
| 5 | Akari Therapeutics | 1,951.18 Bn | 1,951.17 Bn | - |
| 6 | Vertex Pharmaceuticals | 113.69 Bn | 106.44 Bn | 2.59 Bn |
| 7 | Evaxion A | 64.16 Bn | 64.14 Bn | - |
| 8 | Regeneron Pharmaceuticals | 63.94 Bn | 55.18 Bn | 3.31 Bn |
| 9 | Alnylam Pharmaceuticals | 40.13 Bn | 37.12 Bn | 959.66 Mn |
| 10 | Aurinia Pharmaceuticals | 2.03 Bn | 1.65 Bn | 71.20 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 50.81% |
| Dec 31, 2025 | -166.88% |
| Sep 30, 2025 | -3.76% |
| Jun 30, 2025 | -142.77% |
| Mar 31, 2025 | -20.88% |
| Dec 31, 2024 | 471.01% |
| Sep 30, 2024 | 72.63% |
| Jun 30, 2024 | -178.45% |
| Mar 31, 2024 | 886.85% |
| Dec 31, 2023 | 68.24% |
| Sep 30, 2023 | -251.30% |
| Jun 30, 2023 | -122.56% |
| Mar 31, 2023 | 923.72% |
| Dec 31, 2022 | 93.99% |
| Sep 30, 2022 | -210.08% |
| Jun 30, 2022 | 186.05% |
| Mar 31, 2022 | -866.23% |
| Dec 31, 2021 | 83.27% |
| Sep 30, 2021 | -2,064.43% |
| Jun 30, 2021 | 102.48% |
| Mar 31, 2021 | -451.23% |
| Dec 31, 2017 | 202.44% |
| Sep 30, 2017 | -1,108.38% |
| Jun 30, 2017 | -330.48% |
| Sep 30, 2016 | -100.97% |
| Jun 30, 2016 | 36.60% |
| Sep 30, 2015 | 125.81% |